BCAT1 and non-small cell lung carcinoma: A discrepancy exists regarding BCAA levels when knocking down BCAT1 in NSCLC or brain metastasized NSCLC cells, with Zhang et al. showing no change and Mao et al. showing an increase in BCAA levels [27,29].